Your browser doesn't support javascript.
loading
Population pharmacokinetic analysis of TQ-B3203 following intravenous administration of TQ-B3203 liposome injection in Chinese patients with advanced solid tumors.
Li, Xiaoqing; Bo, Yunhai; Yin, Han; Liu, Xiaohong; Li, Xu; Yang, Fen.
Afiliação
  • Li X; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), National drug clinical trial center, Peking University Cancer Hospital & Institute, Beijing, China.
  • Bo Y; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), National drug clinical trial center, Peking University Cancer Hospital & Institute, Beijing, China.
  • Yin H; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), National drug clinical trial center, Peking University Cancer Hospital & Institute, Beijing, China.
  • Liu X; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), National drug clinical trial center, Peking University Cancer Hospital & Institute, Beijing, China.
  • Li X; Chia Tai Tianqing Pharmaceutical Group Co Ltd, Nanjing, Jiangsu, China.
  • Yang F; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), National drug clinical trial center, Peking University Cancer Hospital & Institute, Beijing, China.
Front Pharmacol ; 14: 1102244, 2023.
Article em En | MEDLINE | ID: mdl-36726585

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article